Market volatility intensified today as investors balanced heightened geopolitical tensions with a wave of disappointing corporate earnings. While optimism surrounding a potential Iran-Oman shipping route deal through the Strait of Hormuz briefly supported European and U.S. futures, those sentiments are being challenged by active conflict, as Houthi forces intensified attacks on Saudi oil tankers in the Red Sea and launched fresh assaults in Yemen, complicating regional stability. Concurrently, the technology and consumer sectors faced aggressive repricing, with Datadog shares hitting record lows following disappointing gross margins and Celsius Holdings tumbling after missing revenue estimates. This trend of skepticism toward high-growth valuations was widespread, affecting companies like HubSpot and Fiserv, even as some firms like Alphabet moved to secure capital via bond offerings. In the regulatory landscape, the Department of Government Efficiency (DOGE) faced new scrutiny as a GAO report identified a lack of transparent methodologies for its reported $110 billion in savings, while the D.C. Circuit Court of Appeals reaffirmed the limits of executive privilege in the Peter Navarro contempt case. Amid these pressures, the biotech sector received a boost following the FDA’s approval of Moderna’s mRNA flu vaccine, though overall market sentiment remains sensitive to the interplay between interest rate outlooks and cooling growth expectations.